Efficacy and Safety of Ribociclib in Pre- and Postmenopausal Chinese Women With HR Positive, HER2-negative, Advanced Breast Cancer.
Clinical trial NCT03671330 · COMPLETED
Trial details
- NCT number
- NCT03671330
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-29
- Primary completion
- 2022-04-25
- Enrollment
- 327
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.